Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022?

por Wong, Jeffrey Sum Lung, Leung, Roland, Cheung, Tan To, Yau, Thomas
Publicado 2023

Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC

por Dong, Yawen, Wong, Jeffrey Sum Lung, Sugimura, Ryohichi, Lam, Ka-On, Li, Bryan, Kwok, Gerry Gin Wai, Leung, Roland, Chiu, Joanne Wing Yan, Cheung, Tan To, Yau, Thomas
Publicado 2021

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors

por Wong, Jeffrey Sum Lung, Kwok, Gerry Gin Wai, Tang, Vikki, Li, Bryan Cho Wing, Leung, Roland, Chiu, Joanne, Ma, Ka Wing, She, Wong Hoi, Tsang, Josephine, Lo, Chung Mau, Cheung, Tan To, Yau, Thomas
Publicado 2021

The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong—A Territory-Wide Cohort Study

por Wong, Jeffrey Sum-Lung, Dong, Yawen, Tang, Vikki, Leung, Thomas, Yeung, Cynthia S. Y., Tai, Anna, Law, Ada, Shum, Tracy, Kwok, Gerry Gin-Wai, Li, Bryan Cho-Wing, Leung, Roland, Chiu, Joanne, Ma, Ka-Wing, She, Wong-Hoi, Tsang, Josephine, Cheung, Tan-To, Yau, Thomas
Publicado 2021